廣汽本田及東風本田召回逾25萬輛國產混合動力汽車
根據市場監管總局網站,廣汽本田汽車召回2019年1月4日至2022年12月29日期間生產的部分國產混合動力版皓影(BREEZE)、插電式混合動力版皓影(BREEZE)系列汽車,共87,092輛。東風本田汽車召回2017年6月8日至2022年8月17日期間生產的部分國產混合動力版思威(CR-V)及插電式混合動力版思威(CR-V)系列汽車,共169,000輛。
另外,平治中國即日起,召回生產日期在2021年2月9日至2021年11月18日期間的部分進口GLE SUV汽車,共118輛。而富豪汽車亦即日起,召回2014年12月1日至2023年9月23日期間生產的部分2015至2024年款進口XC90汽車,共1,200輛。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.